⚙
AI-generated deep summary
by claude@2026-07, 2026-07-16
· read from full text
ⓘ
The paper investigated whether a totally implanted bidirectional cortical–basal ganglia neural interface could decode natural movement state in real time during long-term, at-home use rather than short laboratory sessions. Using long-term recordings from motor cortex and pallidum in four subjects with Parkinson’s disease, the authors identified personalized neural signatures of gait state, with state labels determined by wearable sensor measures, and demonstrated onboard real-time classification to drive adaptive stimulation. The study explicitly acknowledges a key limitation that decoding performance in real-world settings and with onboard algorithms had been unknown, and the evidence is based on a small cohort. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Abstract
ABSTRACT Movement decoding from invasive human recordings typically relies on a distributed system employing advanced machine learning algorithms programmed into an external computer for state classification. These brain-computer interfaces are limited to short-term studies in laboratory settings that may not reflect behavior and neural states in the real world. The development of implantable devices with sensing capabilities is revolutionizing the study and treatment of brain circuits. However, it is unknown whether these devices can decode natural movement state from recorded neural activity or accurately classify states in real-time using onboard algorithms. Here, using a totally implanted bidirectional neurostimulator to perform long-term, at-home recordings from the motor cortex and pallidum of four subjects with Parkinson’s disease, we successfully identified highly sensitive and specific personalized signatures of gait state, as determined by wearable sensors. Additionally, we demonstrated the feasibility of using these neural biomarkers to drive adaptive stimulation with the classifier embedded onboard the neurostimulator. These findings offer a pipeline for ecologically valid movement biomarker identification that can advance therapy across a variety of diseases.
Full text
3,189 characters
· extracted from
oa-doi-fallback
· click to expand
ABSTRACT
Movement decoding from invasive human recordings typically relies on a distributed system employing advanced machine learning algorithms programmed into an external computer for state classification. These brain-computer interfaces are limited to short-term studies in laboratory settings that may not reflect behavior and neural states in the real world. The development of implantable devices with sensing capabilities is revolutionizing the study and treatment of brain circuits. However, it is unknown whether these devices can decode natural movement state from recorded neural activity or accurately classify states in real-time using onboard algorithms. Here, using a totally implanted bidirectional neurostimulator to perform long-term, at-home recordings from the motor cortex and pallidum of four subjects with Parkinson’s disease, we successfully identified highly sensitive and specific personalized signatures of gait state, as determined by wearable sensors. Additionally, we demonstrated the feasibility of using these neural biomarkers to drive adaptive stimulation with the classifier embedded onboard the neurostimulator. These findings offer a pipeline for ecologically valid movement biomarker identification that can advance therapy across a variety of diseases.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03582891
Funding Statement
This research was supported by Michael J Fox Foundation (MJFF-010435) (DDW), NIH R01NS130183 (DDW), UCSF Catalyst Grant (DDW, RR, HFA), Tianqiao and Chrissy Chen Institute (DDW).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board (IRB) at the University of California, San Francisco provided formal ethical approval for this study (IRB# 20-32847).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data from this study can be made available upon reasonable request, provided that patient confidentiality is maintained and disclosure standards are met.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.